ALICE LOONEY: Open Payments
NPI 1942288261 · NEWBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,166 in 40 payments from 17 companies in 2025. Trend: 2023 $499 · 2024 $1,536 · 2025 $2,166
Food & beverage: $2,166
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $303 |
| Novo Nordisk Inc | 2 | $237 |
| Collegium Pharmaceutical, Inc. | 13 | $223 |
| AstraZeneca Pharmaceuticals LP | 2 | $190 |
| Boston Scientific Corporation | 1 | $147 |
| Agios Pharmaceuticals, Inc. | 1 | $131 |
| ALK-Abello, Inc | 1 | $129 |
| ABBVIE INC. | 1 | $125 |
| GENZYME CORPORATION | 1 | $125 |
| Lilly USA, LLC | 1 | $122 |
Products named: Auvelity, Belbuca, Intracept, PYRUKYND, Odactra, DUPIXENT, BREZTRI, VRAYLAR.
Industry payments across NY — which companies pay providers there.
